Psoriatic skin lesions induced by tumor-necrosis-factor-alpha-therapy
mag(2013)
摘要
A 46-year-old, caucasian woman suffering from Crohn’s disease and a 35-year-old woman suffering from ankylosing spondylitis were treated with the TNFα blocker infliximab and developed psoriasiform skin lesions. The pathophysiology of this paradoxical clinical response as a newly recognized adverse effect of TNFα antagonists is unknown. According to the literature, this type of newly triggered psoriasis may occur any time after initiation of TNFα antagonist therapy and responds to classic antipsoriatic treatment. The phenomenon warrants attention, especially when considering anti-TNFα treatment in various skin diseases besides psoriasis.
更多查看译文
关键词
psoriatic skin lesions,tumor-necrosis-factor-alpha-therapy tumor-necrosis-factor-alpha-therapy tumor-necrosis-factor-alpha-therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要